SEND V4.0 – What to Expect and When to Expect It
April 24, 2025 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…
CertaraApril 24, 2025
Visualizing SEND Data: Why and How
Senior Director, Product Management Peggy is the Customer Success lead for SEND Explorer. She has…
CertaraApril 21, 2025
Best Practices for Visualization of Nonclinical Study Data in SEND Format (and Beyond)
Thank you for registering for our webinar, Best Practices for Visualization of Nonclinical Study Data…
CertaraApril 15, 2025
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis
February 24, 2025 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…
CertaraFebruary 24, 2025
The Benefits of Real-Time Nonclinical Safety Data Analysis
Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…
CertaraJanuary 27, 2025
CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know
December 3, 2024 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for…
CertaraDecember 3, 2024
Transforming Non-clinical Drug Development with SEND Explorer
Since 1999, Genmab has been developing therapeutic antibodies and antibody-drug conjugates (ADCs) for treating cancer.…
CertaraJuly 8, 2024
What’s New for SEND 2023
This webinar will focus on several changes to the CDISC SEND standard that became active…
CertaraJune 12, 2023
Data Visualization with SEND Data to See What Happened at the Preclinical Phase
SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…
CertaraFebruary 9, 2023
